Transformação sarcomatosa de tumor lipomatoso fibro‐histiocítico hemossiderótico: relato de caso

Fanburg-Smith, 2013, Haemosiderotic fibrolipomatous tumour Browne, 2006, Haemosiderotic fibrolipomatous tumor (so‐called haemosiderotic fibrohistiocytic lipomatous tumor): analysis of 13 new cases in support of a distinct entity, Histopathology, 48, 453, 10.1111/j.1365-2559.2006.02360.x Hallor, 2009, Two genetic pathways, t(1;10) and amplification of 3p11‐12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions, J Pathol, 217, 716, 10.1002/path.2513 Wettach, 2008, Cytogenetic analysis of a hemosiderotic fibrolipomatous tumor, Cancer Genet Cytogenet, 182, 140, 10.1016/j.cancergencyto.2008.01.012 Moretti, 2010, Case report: hemosiderotic fibrohistiocytic lipomatous lesion: a clinicopathologic characterization, Clin Orthop Relat Res, 468, 2808, 10.1007/s11999-010-1242-7 West, 2008, Haemosiderotic fibrohistiocytic lipomatous lesion/tumour of the foot: MRI and histopathology, Skeletal Radiol, 37, 71, 10.1007/s00256-007-0397-0 O’Driscoll, 2015, Radiological imaging features and clinicopathological correlation of hemosiderotic fibrolipomatous tumor: experience in a single tertiary cancer center, Skeletal Radiol, 44, 641, 10.1007/s00256-014-2078-0 Ramalho, 2009, Hemosiderotic fibrohistiocytic lipomatous lesion: case report and review of the literature, Sao Paulo Med J, 127, 174, 10.1590/S1516-31802009000300012 Carter, 2014, TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms, Am J Surg Pathol, 38, 1182, 10.1097/PAS.0000000000000212 Michal, 2016, Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity, Ann Diagn Pathol, 20, 40, 10.1016/j.anndiagpath.2015.10.006